Endocytosis of nanomedicines: The case of glycopeptide engineered PLGA nanoparticles

Pharmaceutics

Volumn 7, Issue 2, 2015, Pages 74-89

  Vilella, Antonietta ^a   Ruozi, Barbara ^a   Belletti, Daniela ^a   Pederzoli, Francesca ^a   Galliani, Marianna ^a   Semeghini, Valentina ^a   Forni, Flavio ^a   Zoli, Michele ^a   Vandelli, Maria Angela ^a   Tosi, Giovanni ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Blood brain barrier; Cellular uptake; Endocytosis; Nanomedicine; Neuron

Indexed keywords

CAVEOLIN; CENTRAL NERVOUS SYSTEM AGENTS; CLATHRIN; GLYCOPEPTIDE; NANOCARRIER; NANOPARTICLE; POLYGLACTIN; POLYGLACTIN NANOPARTICLE; POLYMERIC NANOPARTICLE; RAB PROTEIN; UNCLASSIFIED DRUG;

BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN CELL; CELL MIGRATION; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; ENDOSOME; EXOCYTOSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; NANOENGINEERING; NONHUMAN; PERMEABILITY BARRIER; PROTEIN CONFORMATION; REVIEW; TROPISM; VESICULAR TRANSPORT;

EID: 84937437491     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics7020074     Document Type: Review

References (68)

1. Lo, E.H.; Singhal, A.B.; Torchilin, V.P.; Abbott, N.J. Drug delivery to damaged brain. Brain Res. Rev. 2001, 38, 140-148.
2. Siegal, T.; Zylber-Katz, E. Strategies for increasing drug delivery to the brain: Focus on brain lymphoma. Clin. Pharmacokinet. 2002, 41, 171-186.
3. Tosi, G.; Vergoni, A.V.; Ruozi, B.; Bondioli, L.; Badiali, L.; Rivasi, F.; Costantino, L.; Forni, F.; Vandelli, M.A. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution. J. Control. Release 2010, 145, 49-57.
4. Kreuter, J. Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv. Drug Deliv. Rev. 2014, 71, 2-14.
5. Tosi, G.; Costantino, L.; Ruozi, B.; Forni, F.; Vandelli, M.A. Polymeric nanoparticles for the drug delivery to the central nervous system. Exp. Opin. Drug Deliv. 2008, 5, 155-174.
6. Burkhart, A.; Azizi, M.; Thomsen, M.S.; Thomsen, L.B.; Moos, T. Accessing targeted nanoparticles to the brain: The vascular route. Curr. Med. Chem. 2014, 21, 4092-4099.
7. van der Meel, R.; Vehmeijer, L.J.; Kok, R.J.; Storm, G.; van Gaal, E.V. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status. Adv. Drug Deliv. Rev. 2013, 65, 1284-1298.
8. Nagpal, K.; Singh, S.K.; Mishra, D.N. Nanoparticle mediated brain targeted delivery of gallic acid: In vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity. Drug Deliv. 2012, 19, 378-391.
9. Rip, J.; Chen, L.; Hartman, R.; van den Heuvel, A.; Reijerkerk, A.; van Kregten, J.; van der Boom, B.; Appeldoorn, C.; de Boer, M.; Maussang, D.; de Lange, E.C.; et al. Glutathione PEGylated liposomes: Pharmacokinetics and delivery of cargo across the blood-brain barrier in rats. J. Drug Target. 2014, 22, 460-467.
10. Lindqvist, A.; Rip, J.; Gaillard, P.J.; Björkman, S.; Hammarlund-Udenaes, M. Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: A microdialysis study. Mol. Pharm. 2013, 10, 1533-1541.
11. Gabathuler, R. Approaches to transport therapeutic drugs across the blood brain barrier to treat brain diseases. Neurobiol. Dis. 2010, 37, 48-57.
12. Fiori, A.; Cardelli, P.; Negri, L.; Savi, M.R.; Strom, R.; Erspamer, V. Deltorphin transport across the blood-brain barrier. Proc. Natl. Acad. Sci. USA 1997, 94, 9469-9474.
13. Roberts, R.L.; Fine, R.E.; Sandra, A. Receptor-mediated endocytosis of transferrin at the bloodbrain barrier. J. Cell Sci. 1993, 104, 521-532.
14. Tabernero, A.; Velasco, A.; Granda, B.; Lavado, E.M.; Medina, J.M. Transcytosis of albumin in astrocytes activates the sterol regulatory element-binding protein-1, which promotes the synthesis of the neurotrophic factor oleic acid. J. Biol. Chem. 2002, 277, 4240-4246.
15. Witt, K.A.; Huber, J.D.; Egleton, R.D.; Davis, T.P. Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect. J. Pharmacol. Exp. Ther. 2000, 295, 972-978.
16. Pang, Z.; Lu, W.; Gao, H.; Hu, K.; Chen, J.; Zhang, C.; Gao, X.; Jiang, X.; Zhu, C. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J. Control. Release 2008, 128, 120-127.
17. Shi, N.; Pardridge, W.M. Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. USA 2000, 97, 7567-7572.
18. Shi, N.; Boado, R.J.; Pardridge, W.M. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm. Res. 2001, 18, 1091-1095.
19. Huwyler, J.; Wu, D.; Pardridge, W.M. Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. USA 1996, 93, 14164-14169.
20. Zhang, Z.J.; Reynolds, G.P. A selective decrease in the relative density of parvalbuminimmunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 2002, 55, 1-10.
21. Zhang, Y.; Schlachetzki, F.; Pardridge, W.M. Global non-viral gene transfer to the primate brain following intravenous administration. Mol. Ther. 2003, 7, 11-18.
22. Zhang, Y.; Schlachetzki, F.; Zhang, Y.F.; Boado, R.J.; Pardridge, W.M. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. Hum. Gene Ther. 2004, 15, 339-350.
23. Kreuter, J.; Shamenkov, D.; Petrov, V.; Ramge, P.; Cychutek, K.; Koch-Brandt, C.; Alyautdin, R. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 2002, 10, 317-325.
24. Egleton, R.D.; Davis, T.P. Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx 2005, 2, 44-53.
25. Lowery, J.J.; Yeomans, L.; Keyari, C.M.; Davis, P.; Porreca, F.; Knapp, B.I.; Bidlack, J.M.; Bilsky, E.J.; Polt, R. Glycosylation improves the central effects of DAMGO. Chem. Biol. Drug Design 2007, 69, 41-47.
26. Costantino, L.; Gandolfi, F.; Tosi, G.; Rivasi, F.; Vandelli, M.A.; Forni, F. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J. Control. Release 2005, 108, 84-96.
27. Polt, R.; Dhanasekaran, M.; Keyari, C.M. Glycosylated neuropeptides: A new vista for neuropsychopharmacology? Med. Res. Rev. 2005, 25, 557-585.
28. Costantino, L.; Gandolfi, F.; Bossy-Nobs, L.; Tosi, G.; Gurny, R.; Rivasi, F.; Vandelli, M.A.; Forni, F. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures. Biomaterials 2006, 27, 4635-4645.
29. Tosi, G.; Rivasi, F.; Gandolfi, F.; Costantino, L.; Vandelli, M.A.; Forni, F. Conjugated poly(D,Llactide- co-glycolide) for the preparation of in vivo detectable nanoparticles. Biomaterials 2005, 26, 4189-4195.
30. Tosi, G.; Costantino, L.; Rivasi, F.; Ruozi, B.; Leo, E.; Vergoni, A.V.; Tacchi, R.; Bertolini, A.; Vandelli, M.A.; Forni, F. Targeting the central nervous system: In vivo experiments with peptidederivatized nanoparticles loaded with Loperamide and Rhodamine-123. J. Control. Release 2007, 122, 1-9.
31. Tosi, G.; Ruozi, B.; Belletti, D.; Vilella, A.; Zoli, M.; Vandelli, M.A.; Forni, F. Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents. Nanomedicine 2013, 8, 1373-1383.
32. Tosi, G.; Ruozi, B.; Belletti, D.; Vilella, A.; Zoli, M.; Vandelli, M.A.; Forni, F. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier. Nanomedicine 2011, 6, 423-436.
33. Sahay, G.; Alakhova, D.Y.; Kabanov, A.V. Endocytosis of nanomedicines. J. Control. Release 2010, 145, 182-195.
34. Duncan, R.; Richardson, S.C. Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: Opportunities and challenges. Mol. Pharm. 2012, 9, 2380-2402.
35. Meijering, B.D.; Juffermans, L.J.; van Wamel, A.; Henning, R.H.; Zuhorn, I.S.; Emmer, M.; Versteilen, A.M.; Paulus, W.J.; van Gilst, W.H.; Kooiman, K.; et al. Ultrasound and microbubbletargeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ. Res. 2009, 104, 679-687.
36. Daneman, R. The blood-brain barrier in health and disease. Ann. Neurol. 2012, 72, 648-672.
37. Lossinsky, A.S.; Shivers, R.R. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Rev. Histol. Histopathol. 2004, 19, 535-564.
38. Hawkins, B.T.; Davis, T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57, 173-185.
39. Abbott, N.J.; Friedman, A. Overview and introduction: The blood-brain barrier in health and disease. Epilepsia 2012, 53 (Suppl 6), 1-6.
40. Pauling, L.; Corey, R.B.; Branson, M.R. The structure of proteins: Two hydrogen-bonded helical configurations of the polypeptide chain. Proc. Natl. Acad. Sci. USA 1951, 37, 205-211.
41. Dhanasekaran, M.; Palian, M.M.; Alves, I.; Yeomans, L.; Keyari, C.M.; Davis, P.; Bilsky, E.J.; Egleton, R.D.; Yamamura, H.I.; Jacobsen, N.E.; et al. Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers. J. Am. Chem. Soc. 2005, 127, 5435-5448.
42. McMahon, H.T.; Gallop, J. Membrane curvature and mechanisms of dynamic cell membrane remodeling. Nature 2005, 438, 590-596.
43. Zimmemberg, G.; Kozlov, M.M. How proteins produce cellular membrane curvature. Nat. Rev. Mol. Cell. Biol. 2006, 7, 9-19.
44. Nassif, X.; Bourdoulous, S.; Eugene, E.; Couraud, P.O. How do extracellular pathoges cross the blood brain barrier? Trends Microbiol. 2002, 10, 227-232.
45. Coureuil, M.; Mikaty, G.; Miller, F.; Lécuyer, H.; Bernard, C.; Bourdoulous, S.; Duménil, G.; Mège, R.M.; Weksler, B.B.; Romero, I.A.; et al. Meningococcal type IV Pili recruit the polarity complex to cross the brain endothelium. Science 2009, 325, 83-87.
46. Prasadaro, N.V.; Wass, C.A.; Weiser, J.N.; Stins, M.F.; Huang, S.H.; Kim, K.S. Outer membrane protein A-promoted of Escherichi coli contributes to invasiton of brain microvascular endothelial cell. Infect. Immun. 1996, 64, 146-153.
47. Vilella, A.; Tosi, G.; Grabrucker, A.M.; Ruozi, B.; Belletti, D.; Vandelli, M.A.; Boeckers, T.M.; Forni, F.; Zoli, M. Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cellspecific uptake and distribution. J. Control. Release 2014, 174, 195-201.
48. Tosi, G.; Vilella, A.; Chhabra, R.; Schmeisser, M.J.; Boeckers, T.M.; Ruozi, B.; Vandelli, M.A.; Forni, F.; Zoli, M.; Grabrucker, A.M. Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport. J. Control. Release 2014, 177, 96-107.
49. Chhabra, R.; Grabrucker, A.M.; Veratti, P.; Belletti, D.; Boeckers, T.M.; Vandelli, M.A.; Forni, F.; Tosi, G.; Ruozi, B. Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release. Int. J. Pharm. 2014, 471, 349-357.
50. Grant, B.D.; Donaldson, J.G. Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 2009, 10, 597-608.
51. Zerial, M.; McBride, H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001, 2, 107-117.
52. Van Der Sluijs, P.; Hull, M.; Zahraoui, A.; Tavitian, A.; Goud, B.; Mellman, I. The small GTPbinding protein rab4 is associated with early endosomes. Proc. Natl. Acad. Sci. USA 1991, 88, 6313-6317.
53. Gorvel, J.P.; Chavrier, P.; Zerial, M.; Gruenberg, J. rab5 controls early endosome fusion in vitro. Cell 1991, 64, 915-925.
54. Bucci, C.; Parton, R.G.; Mather, I.H.; Stunnenberg, H.; Simons, K.; Hoflack, B.; Zerial, M. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 1992, 70, 715-728.
55. Stenmark, H.; Valencia, A.; Martinez, O.; Ullrich, O.; Goud, B.; Zerial, M. Distinct structural elements of rab5 define its functional specificity. EMBO J. 1994, 13, 575-583.
56. McLauchlan, H.; Newell, J.; Morrice, N.; Osborne, A.; West, M.; Smythe, E. A novel role for Rab5-GDI in ligand sequestration into clathrin-coated pits. Curr. Biol. 1998, 8, 34-45.
57. van der Sluijs, P.; Hull, M.; Webster, P.; Mâle, P.; Goud, B.; Mellman, I. The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell 1992, 70, 729-740.
58. Ullrich, O.; Reinsch, S.; Urbe, S.; Zerial, M.; Parton, R.G. Rab11 regulates recycling through the pericentriolar recycling endosome. J. Cell Biol. 1996, 135, 913-924.
59. Wilcke, M.; Johannes, L.; Galli, T.; Mayau, V.; Goud, B.; Salamero, J. Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-golgi network. J. Cell Biol. 2000, 151, 1207-1220.
60. Feng, Y.; Press, B.; Wandinger-Ness, A.; Rab 7: An important regulator of late endocytic membrane traffic. J. Cell Biol. 1995, 131, 1435-1452.
61. Vitelli, R.; Santillo, M.; Lattero, D.; Chiariello, M.; Bifulco, M.; Bruni, C.B.; Bucci, C. Role of the small GTPase Rab7 in the late endocytic pathway. J. Biol. Chem. 1997, 272, 4391-4397.
62. Lombardi, D.; Soldati, T.; Riederer, M.A.; Goda, Y.; Zerial, M.; Pfeffer, S.R. Rab9 Functions in Transport between Late Endosomes and the Trans Golgi Network. EMBO J. 1993, 12, 677-682.
63. Pascolo, L.; Bortot B.; Benseny-Cases, N.; Gianoncelli, A.; Tosi, G.; Ruozi, B.; Rizzardi, C.; De Martino, E.; Vandelli, M.A.; Severini, G.M. Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy. Int. J. Nanomed. 2014, 9, 2791-2801.
64. Tosi, G.; Bondioli, L.; Ruozi, B.; Badiali, L.; Severini, G.M.; Biffi, S.; De Vita, A.; Bortot, B.; Dolcetta, D.; Forni, F.; et al. NIR-labeled nanoparticles engineered for brain targeting: In vivo optical imaging application and fluorescent microscopy evidences. J. Neural Transm. 2011, 118, 145-153.
65. Bondioli, L.; Costantino, L.; Ballestrazzi, A.; Lucchesi, D.; Boraschi, D.; Pellati, F.; Benvenuti, S.; Tosi, G.; Vandelli, M.A. PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid. Biomaterials 2010, 31, 3395-3403.
66. Wong, Y.Y.; Markham, K.; Xu, Z.P.; Chen, M.; Max Lu, G.Q.; Bartlett, P.F.; Cooper, H.M. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials 2010, 31, 8770-8779.
67. Harush-Frenkel, O.; Rozentur, E.; Benita, S.; Altschuler, Y.; Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 2008, 9, 435-443.
68. Wilson, J.M.; de Hoop, M.; Zorzi, N.; Toh, B.H.; Dotti, C.G.; Parton, R.G. EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts. Mol. Biol. Cell 2000, 11, 2657-2671.